MICHAEL E. MACK

5.1k citations
124 papers · 4.3k · 2 hit papers · h-index 34

Impact in

  • Rheumatology top 0.5%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Spondyloarthritis Studies and Treatments 19
    • Integrated Circuits and Semiconductor Failure Analysis 16
    • Semiconductor materials and devices 15
    • Silicon and Solar Cell Technologies 10
    • Laser Design and Applications 8

MICHAEL E. MACK

115 papers receiving 3.9k citations

MICHAEL E. MACK's Hit Papers

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study 2009 · 515 citations
5150+6+12Years since publication100200300400500

Peers

MICHAEL E. MACK
Comparison fields: 5 of 135
  • Rheumatology 1.6k
  • Hematology 422
  • Infectious Diseases 677
  • Immunology 681
  • Atomic and Molecular Physics, and Optics 823
Replace Kamran Badizadegan with:
Kamran Badizadegan United States
Atsushi Ogata Japan
Kôji Watanabe Japan
John A. McIntyre United States
Hideki Ueno Japan
Peter F. Hahn United States
Christian P. Morath Germany
Ionita Calin Ghiran United States
Natacha Bessis France
King C. Li United States
MICHAEL E. MACK relative to Kamran Badizadegan United States Kamran Badizadegan's profile →
Citations per field
00.5×2×4×6×7.4×
Kamran Badizadegan · 1×
Citations per year

Countries citing papers authored by MICHAEL E. MACK

Since Specialization
Citations

This map shows the geographic impact of MICHAEL E. MACK's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MICHAEL E. MACK with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MICHAEL E. MACK more than expected).

Fields of papers citing papers by MICHAEL E. MACK

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MICHAEL E. MACK. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MICHAEL E. MACK. The network helps show where MICHAEL E. MACK may publish in the future.

Co-authors

The 25 scholars most cited alongside MICHAEL E. MACK, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with MICHAEL E. MACK Line = papers co-authored together MICHAEL E. MACK links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study
Hit paper breakdown →
2009515
2
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial
Hit paper breakdown →
2008492
3
Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
1996273
4 2012183
5 1969178
6 1997141
7 2015123
8 1996101
9 200592
10 201286
11 201186
12 198983
13 201281
14 201379
15 197275
16 199766
17 197062
18 196858
19 196856
20 196956

About MICHAEL E. MACK

MICHAEL E. MACK is a scholar working on Rheumatology, Electrical and Electronic Engineering, Atomic and Molecular Physics, and Optics, Computational Mechanics and Infectious Diseases, having authored 124 papers that have together received 4.3k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (19 papers), Integrated Circuits and Semiconductor Failure Analysis (16 papers), Semiconductor materials and devices (15 papers), Laser-Matter Interactions and Applications (11 papers), Ion-surface interactions and analysis (11 papers), Silicon and Solar Cell Technologies (10 papers), Advanced Fiber Laser Technologies (9 papers) and Laser Design and Applications (8 papers). The work is most often cited by research in Rheumatology (1.6k citations), Hematology (422 citations), Infectious Diseases (677 citations), Immunology (681 citations) and Atomic and Molecular Physics, and Optics (823 citations). MICHAEL E. MACK has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Anna M. Beutler, Sudha Visvanathan, Désirée van der Heijde, Benjamin L. Hsu, Jürgen Braun, Edward T. Zito, Dafna Gladman, Robert Davies Inman, Gerald G. Krueger and Iain B. McInnes. Their work appears in journals such as Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms, Lara D. Veeken, Applied Physics Letters, Annals of the Rheumatic Diseases and Applied Optics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact